Literature DB >> 11086024

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

S Cenci1, M N Weitzmann, C Roggia, N Namba, D Novack, J Woodring, R Pacifici.   

Abstract

Estrogen deficiency induces bone loss by upregulating osteoclastogenesis by mechanisms not completely defined. We found that ovariectomy-enhanced T-cell production of TNF-alpha, which, acting through the TNF-alpha receptor p55, augments macrophage colony-stimulating factor-induced (M-CSF-induced) and RANKL-induced osteoclastogenesis. Ovariectomy failed to induce bone loss, stimulate bone resorption, or increase M-CSF- and RANKL-dependent osteoclastogenesis in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. These findings demonstrate that the ability of estrogen to target T cells, suppressing their production of TNF-alpha, is a key mechanism by which estrogen prevents osteoclastic bone resorption and bone loss.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086024      PMCID: PMC381439          DOI: 10.1172/JCI11066

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction.

Authors:  M L Salem; G Matsuzaki; K Kishihara; G A Madkour; K Nomoto
Journal:  Int Arch Allergy Immunol       Date:  2000-02       Impact factor: 2.749

2.  M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.

Authors:  S Cenci; M N Weitzmann; M A Gentile; M C Aisa; R Pacifici
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  An athymic nude mutation in the rat.

Authors:  M F Festing; D May; T A Connors; D Lovell; S Sparrow
Journal:  Nature       Date:  1978-07-27       Impact factor: 49.962

4.  Activated T lymphocytes support osteoclast formation in vitro.

Authors:  N J Horwood; V Kartsogiannis; J M Quinn; E Romas; T J Martin; M T Gillespie
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

5.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

6.  Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

Authors:  N K Shevde; A C Bendixen; K M Dienger; J W Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone.

Authors:  S Kuroda; S Kasugai; S Oida; T Iimura; K Ohya; T Ohyama
Journal:  Bone       Date:  1999-10       Impact factor: 4.398

8.  T lymphocyte subsets in osteoporosis. Effect of 1-alpha hydroxyvitamin D3.

Authors:  T Fujita; T Matsui; Y Nakao; S Watanabe
Journal:  Miner Electrolyte Metab       Date:  1984

9.  T-cell development in the absence of a thymus: the number, the phenotype, and the functional capacity of T lymphocytes in nude mice.

Authors:  W F Chen; R Scollay; K Shortman; M Skinner; J Marbrook
Journal:  Am J Anat       Date:  1984-07

10.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  207 in total

Review 1.  The mechanisms of estrogen regulation of bone resorption.

Authors:  B L Riggs
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

3.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Genetic responses to nanostructured calcium-phosphate-coated implants.

Authors:  R Jimbo; Y Xue; M Hayashi; H O Schwartz-Filho; M Andersson; K Mustafa; A Wennerberg
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

5.  Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

Authors:  Simone Cenci; Gianluca Toraldo; M Neale Weitzmann; Cristiana Roggia; Yuhao Gao; Wei Ping Qian; Oscar Sierra; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

6.  Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Authors:  Guitty Eghbali-Fatourechi; Sundeep Khosla; Arunik Sanyal; William J Boyle; David L Lacey; B Lawrence Riggs
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

7.  Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds.

Authors:  Gary A Fielding; Amit Bandyopadhyay; Susmita Bose
Journal:  Dent Mater       Date:  2011-11-01       Impact factor: 5.304

Review 8.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

9.  Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Authors:  Philip M Grant; Virginia Sheikh; Rebecca DerSimonian; Adam Rupert; Gregg Roby; Alice Pau; Michael C Sneller; Sheryl-Vi Rico; Todd T Brown; Irini Sereti
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-21       Impact factor: 2.205

10.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.